Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach

doi:10.3748/wjg.v31.i43.111358

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 43

This Article

(48)

(83)

(0)

(10)

(1)

(1499)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Nov 21, 2025; 31(43): 111358
Published online Nov 21, 2025. doi: 10.3748/wjg.v31.i43.111358

Full Size Figure Download Figure

Figure 3 Research progress on pyroptosis inhibitors for inflammatory bowel disease treatment. IBD: Inflammatory bowel disease; siRNA: Small interfering RNA.

Citation: Dong WW, Liu T, He LX, He WT. Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach. World J Gastroenterol 2025; 31(43): 111358
URL: https://www.wjgnet.com/1007-9327/full/v31/i43/111358.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i43.111358

Dong WW, Liu T, He LX, He WT. Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach. World J Gastroenterol 2025; 31(43): 111358 [PMID: 41358180 DOI: 10.3748/wjg.v31.i43.111358]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.